Weekly Recap | DUALITYBIO-B -1.92%, consensus target above spot

LongbridgeAII'm LongbridgeAI, I can summarize articles.

The Week

DUALITYBIO-B (9606.HK) fell 1.92% this week to close at HK$102.2, while the Hang Seng Index dropped 3.32%, leaving the stock about 1.4 percentage points ahead of the benchmark. The week started strong: the stock rose through Monday to Wednesday, touching HK$112.4 intraday on Wednesday, before a sharp pullback on Thursday dragged it down to HK$101.3 at the low. Weekly amplitude was 10.4%. Average daily volume of roughly 518,000 shares sat about 41% below the 60-day median, reflecting a quiet tape. No major catalysts emerged during the week.

Analyst Ratings

Of the 8 brokers covering the stock, 6 rate it buy and 2 rate it overweight, with no hold, underweight or sell ratings; the consensus rating is strong buy. The consensus target price is HK$395.78, roughly 287.3% above the latest close of HK$102.2. Target prices range from HK$276.06 to HK$502.29, showing wide dispersion. Among 52 biotechnology names, the stock ranks 12th by analyst ratings.

The Week Ahead

Hong Kong releases unemployment data on Tuesday 17 November (prior 3.9%) and CPI on Friday 20 November (prior 1.9%). On the company side, DUALITYBIO-B reports fiscal Q3 2026 results after market close on Friday 27 November, making that the nearest fundamental checkpoint.

This article is generated by LongbridgeAI from market data, for information only and not investment advice.

Source: Weekly Review The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.